Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetes & Metabolism

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12149600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus.

  2009cited by this paper
• Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency

  2004cited by this paper
• New data on the mechanisms of hypermagnesuria in type I diabetes mellitus.

  2001cited by this paper
• Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes.

  2001cited by this paper
• Hyperglycaemia enhances renal magnesium excretion in Type 1 diabetic patients

  2000cited by this paper
• [Magnesium supplementation to patients with type II diabetes].

  1999cited by this paper
• Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes.

  1999cited by this paper
• Oral magnesium supplementation in insulin‐requiring Type 2 diabetic patients

  1998cited by this paper
• Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study.

  1998cited by this paper
• Methodological aspects of measuring human skeletal muscle electrolyte content and ouabain binding capacity.

  1998cited by this paper
• The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes

  1998cited by this paper
• Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study.

  1995cited by this paper
• Insulin Increases Renal Magnesium Excretion: A Possible Cause of Magnesium Depletion in Hyperinsulinaemic States

  1995cited by this paper
• Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Hypomagnesemia in Type II Diabetes: Effect of a 3-Month Replacement Therapy

  1995cited by this paper
• Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics.

  1994cited by this paper
• Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients.

  1994cited by this paper
• Changes of calcemia and magnesemia during oral glucose tolerance test (OGTT) in relation to glucose tolerance.

  1994cited by this paper
• Effect of Magnesium Treatment on Glycemic Control and Metabolic Parameters in NIDDM Patients

  1994cited by this paper
• Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.

  1993cited by this paper
• Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death.

  1990cited by this paper
• Oral magnesium supplementation in patients with essential hypertension.

  1989cited by this paper
• Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.

  1989cited by this paper
• Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects

  1989cited by this paper
• Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: effects on magnesium and potassium levels and on insulin requirements.

  1988cited by this paper
• Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test.

  1988cited by this paper
• Magnesium Deficiency in IDDM Related to Level of Glycosylated Hemoglobin

  1986cited by this paper
• Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: a clinical assay

  1984cited by this paper
• The muscle in diabetes mellitus. A histologic (light and electron microscope) and biochemical study by means of needle biopsy.

  1970cited by this paper

• Why typos in DNA may help to fuel atherogenesis and inflammation prior to heart attacks, ischemic heart disease, and sudden-death ischemic heart disease: roles of unrecognized ionized hypomagnesemia and epigenetics

  2020cites this paper
• The Expression of Platelet-Activating Factor Is Induced by Low Extracellular Mg2+ in Aortic, Cerebral and Neonatal Coronary Vascular Smooth Muscle; Cross Talk with Ceramide Production, NF–kB and Proto-Oncogenes: Possible Links to Atherogenesis and Sudden

  2020cites this paper
• Importance of Ionized Magnesium Measurements in Physiology and Medicine and the Need for Ion-selective Electrodes

  2016cites this paper
• Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.

  2014cites this paper
• Serum magnesium levels in non-diabetic offspring of patients with Type 2 diabetes mellitus.

  2004cites this paper
• Current literature in diabetes.

  2002cites this paper
• Current literature in diabetes

  2001cites this paper